Abnormalities of lymphocyte subsets and anti-LAV/HTLV-III status in Greek hemophiliacs. 1986

H Choremi, and J Economidou, and K Psarra, and E Sidiri, and T Mandalaki, and C Louizou, and A Gialeraki, and C Markakis, and C Papaevangelou, and G Kallinicos

Peripheral blood lymphocyte subsets and the incidence of LAV/HTLV-III antibodies were studied in 63 patients with hemophilia A who had been transfused with a low dose regimen of commercial (U.S.A.) factor VIII concentrates. Five patients with hemophilia B were also included in this study. In hemophilia A patients a significant reduction in the percentage and absolute numbers of T4+ cells and of the T4/T8 ratio and a significant increase in the percentage of T8+ and Leu-7+ cells were observed. These abnormalities were independent of the presence of anti-LAV/HTLV-III. In hemophilia B patients a significant increase of T8+ cells and a decrease of T4/T8 ratio was noted while the percentage of Leu-7+ cells was normal. A significant negative correlation of F VIII units transfused and T4/T8 ratio was seen only in LAV/HTLV (-) patients, suggesting that F VIII per se could cause immunodysregulation. Seropositive patients were found to have consumed a larger amount of F VIII units than seronegative patients during the period 1980-1984 (p less than 0.005).

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D005169 Factor VIII Factor VIII of blood coagulation. Antihemophilic factor that is part of the factor VIII/von Willebrand factor complex. Factor VIII is produced in the liver and acts in the intrinsic pathway of blood coagulation. It serves as a cofactor in factor X activation and this action is markedly enhanced by small amounts of thrombin. Coagulation Factor VIII,Factor VIII Clotting Antigen,Factor VIII Coagulant Antigen,Factor VIII Procoagulant Activity,Thromboplastinogen,Blood Coagulation Factor VIII,F VIII-C,Factor 8,Factor 8 C,Factor Eight,Factor VIIIC,Hyate-C,Hyatt-C,F VIII C,Hyate C,HyateC,Hyatt C,HyattC
D006467 Hemophilia A The classic hemophilia resulting from a deficiency of factor VIII. It is an inherited disorder of blood coagulation characterized by a permanent tendency to hemorrhage. Factor VIII Deficiency,Hemophilia,Autosomal Hemophilia A,Classic Hemophilia,Deficiency, Factor VIII,Factor 8 Deficiency, Congenital,Factor VIII Deficiency, Congenital,Haemophilia,Hemophilia A, Congenital,Hemophilia, Classic,As, Autosomal Hemophilia,Autosomal Hemophilia As,Classic Hemophilias,Congenital Hemophilia A,Congenital Hemophilia As,Hemophilia A, Autosomal,Hemophilia As,Hemophilia As, Autosomal,Hemophilia As, Congenital,Hemophilias, Classic
D006678 HIV Human immunodeficiency virus. A non-taxonomic and historical term referring to any of two species, specifically HIV-1 and/or HIV-2. Prior to 1986, this was called human T-lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV). From 1986-1990, it was an official species called HIV. Since 1991, HIV was no longer considered an official species name; the two species were designated HIV-1 and HIV-2. AIDS Virus,HTLV-III,Human Immunodeficiency Viruses,Human T-Cell Lymphotropic Virus Type III,Human T-Lymphotropic Virus Type III,LAV-HTLV-III,Lymphadenopathy-Associated Virus,Acquired Immune Deficiency Syndrome Virus,Acquired Immunodeficiency Syndrome Virus,Human Immunodeficiency Virus,Human T Cell Lymphotropic Virus Type III,Human T Lymphotropic Virus Type III,Human T-Cell Leukemia Virus Type III,Immunodeficiency Virus, Human,Immunodeficiency Viruses, Human,Virus, Human Immunodeficiency,Viruses, Human Immunodeficiency,AIDS Viruses,Human T Cell Leukemia Virus Type III,Lymphadenopathy Associated Virus,Lymphadenopathy-Associated Viruses,Virus, AIDS,Virus, Lymphadenopathy-Associated,Viruses, AIDS,Viruses, Lymphadenopathy-Associated
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000163 Acquired Immunodeficiency Syndrome An acquired defect of cellular immunity associated with infection by the human immunodeficiency virus (HIV), a CD4-positive T-lymphocyte count under 200 cells/microliter or less than 14% of total lymphocytes, and increased susceptibility to opportunistic infections and malignant neoplasms. Clinical manifestations also include emaciation (wasting) and dementia. These elements reflect criteria for AIDS as defined by the CDC in 1993. AIDS,Immunodeficiency Syndrome, Acquired,Immunologic Deficiency Syndrome, Acquired,Acquired Immune Deficiency Syndrome,Acquired Immuno-Deficiency Syndrome,Acquired Immuno Deficiency Syndrome,Acquired Immuno-Deficiency Syndromes,Acquired Immunodeficiency Syndromes,Immuno-Deficiency Syndrome, Acquired,Immuno-Deficiency Syndromes, Acquired,Immunodeficiency Syndromes, Acquired,Syndrome, Acquired Immuno-Deficiency,Syndrome, Acquired Immunodeficiency,Syndromes, Acquired Immuno-Deficiency,Syndromes, Acquired Immunodeficiency
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

H Choremi, and J Economidou, and K Psarra, and E Sidiri, and T Mandalaki, and C Louizou, and A Gialeraki, and C Markakis, and C Papaevangelou, and G Kallinicos
June 1986, JAMA,
H Choremi, and J Economidou, and K Psarra, and E Sidiri, and T Mandalaki, and C Louizou, and A Gialeraki, and C Markakis, and C Papaevangelou, and G Kallinicos
April 1986, Medicina clinica,
H Choremi, and J Economidou, and K Psarra, and E Sidiri, and T Mandalaki, and C Louizou, and A Gialeraki, and C Markakis, and C Papaevangelou, and G Kallinicos
February 1987, Blut,
H Choremi, and J Economidou, and K Psarra, and E Sidiri, and T Mandalaki, and C Louizou, and A Gialeraki, and C Markakis, and C Papaevangelou, and G Kallinicos
January 1986, The New England journal of medicine,
H Choremi, and J Economidou, and K Psarra, and E Sidiri, and T Mandalaki, and C Louizou, and A Gialeraki, and C Markakis, and C Papaevangelou, and G Kallinicos
December 1986, American journal of hematology,
H Choremi, and J Economidou, and K Psarra, and E Sidiri, and T Mandalaki, and C Louizou, and A Gialeraki, and C Markakis, and C Papaevangelou, and G Kallinicos
June 1985, Blood,
H Choremi, and J Economidou, and K Psarra, and E Sidiri, and T Mandalaki, and C Louizou, and A Gialeraki, and C Markakis, and C Papaevangelou, and G Kallinicos
February 1987, Clinical chemistry,
H Choremi, and J Economidou, and K Psarra, and E Sidiri, and T Mandalaki, and C Louizou, and A Gialeraki, and C Markakis, and C Papaevangelou, and G Kallinicos
December 1985, Journal of clinical chemistry and clinical biochemistry. Zeitschrift fur klinische Chemie und klinische Biochemie,
H Choremi, and J Economidou, and K Psarra, and E Sidiri, and T Mandalaki, and C Louizou, and A Gialeraki, and C Markakis, and C Papaevangelou, and G Kallinicos
January 1986, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke,
H Choremi, and J Economidou, and K Psarra, and E Sidiri, and T Mandalaki, and C Louizou, and A Gialeraki, and C Markakis, and C Papaevangelou, and G Kallinicos
December 1986, AIDS research,
Copied contents to your clipboard!